Kintor Pharmaceutical Completed 1st Subject Enrolment in a Phase 2 Clinical Trial of Acne Drug in China
Kintor Pharmaceutical Completed 1st Subject Enrolment in a Phase 2 Clinical Trial of Acne Drug in China
康拓药业在中国完成了痤疮药物二期临床试验的第一阶段招募。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册